Follow
Elai Davicioni
Elai Davicioni
Veracyte
Verified email at veracyte.com
Title
Cited by
Cited by
Year
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
7652017
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ...
Nature genetics 45 (11), 1392-1398, 2013
7232013
Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy
N Erho, A Crisan, IA Vergara, AP Mitra, M Ghadessi, C Buerki, ...
PloS one 8 (6), e66855, 2013
6622013
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ...
Nature communications 5 (1), 5383, 2014
6002014
Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition
V Evdokimova, C Tognon, T Ng, P Ruzanov, N Melnyk, D Fink, A Sorokin, ...
Cancer cell 15 (5), 402-415, 2009
5482009
Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
E Lalonde, AS Ishkanian, J Sykes, M Fraser, H Ross-Adams, N Erho, ...
The lancet oncology 15 (13), 1521-1532, 2014
3802014
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population
RJ Karnes, EJ Bergstralh, E Davicioni, M Ghadessi, C Buerki, AP Mitra, ...
The Journal of urology 190 (6), 2047-2053, 2013
3512013
Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas
E Davicioni, F Graf Finckenstein, V Shahbazian, JD Buckley, TJ Triche, ...
Cancer research 66 (14), 6936-6946, 2006
3302006
Molecular classification of rhabdomyosarcoma—genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group
E Davicioni, MJ Anderson, FG Finckenstein, JC Lynch, SJ Qualman, ...
The American journal of pathology 174 (2), 550-564, 2009
3052009
Associations of luminal and basal subtyping of prostate cancer with prognosis and response to androgen deprivation therapy
SG Zhao, SL Chang, N Erho, M Yu, J Lehrer, M Alshalalfa, C Speers, ...
JAMA oncology 3 (12), 1663-1672, 2017
2732017
RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1
JR Prensner, S Zhao, N Erho, M Schipper, MK Iyer, SM Dhanasekaran, ...
The lancet oncology 15 (13), 1469-1480, 2014
2672014
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men
AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ...
European urology 69 (1), 157-165, 2016
2622016
Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy
RB Den, K Yousefi, EJ Trabulsi, F Abdollah, V Choeurng, FY Feng, ...
Journal of Clinical Oncology 33 (8), 944-951, 2015
2352015
Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort
MR Cooperberg, E Davicioni, A Crisan, RB Jenkins, M Ghadessi, ...
European urology 67 (2), 326-333, 2015
2212015
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ...
The lancet oncology 17 (11), 1612-1620, 2016
2192016
Individual patient-level meta-analysis of the performance of the decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease
DE Spratt, K Yousefi, S Deheshi, AE Ross, RB Den, EM Schaeffer, ...
Journal of Clinical Oncology 35 (18), 1991-1998, 2017
2182017
FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes
EJ Adams, WR Karthaus, E Hoover, D Liu, A Gruet, Z Zhang, H Cho, ...
Nature 571 (7765), 408-412, 2019
2082019
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy …
EA Klein, K Yousefi, Z Haddad, V Choeurng, C Buerki, AJ Stephenson, ...
European urology 67 (4), 778-786, 2015
1982015
Development and validation of a novel integrated clinical-genomic risk group classification for localized prostate cancer
DE Spratt, J Zhang, M Santiago-Jiménez, RT Dess, JW Davis, RB Den, ...
Journal of Clinical Oncology 36 (6), 581-590, 2018
1972018
The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis
Y Yu, E Davicioni, TJ Triche, G Merlino
Cancer research 66 (4), 1982-1989, 2006
1932006
The system can't perform the operation now. Try again later.
Articles 1–20